Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1636-2026Class II

Tandem pumps are battery-operated infusion pumps capable of both basal and bolus delivery of insulin. The...

Tandem Diabetes Care, Inc. / initiated 2026-01-30 / Open, Classified

Tandem Diabetes Care, Inc. began a recall of Tandem pumps are battery-operated infusion pumps capable of both basal and bolus delivery of insulin. The pumps utilize a motor-driven mechanism to deliver... on . FDA classified it as Class II and gives the reason as "The Czech language user guide contained multiple translation errors. The most significant error was that it incorrectly instructs users to verify that the infusion set is connected to the body, when it should instead...". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-1636-2026
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Tandem Diabetes Care, Inc.
Product
Tandem pumps are battery-operated infusion pumps capable of both basal and bolus delivery of insulin. The pumps utilize a motor-driven mechanism to deliver insulin from within a disposable cartridge, through an infusion set, into a patient s subcutaneous tissue. As with current insulin infusion pumps on the U.S. market, the desired timing and quantity of the insulin delivery is programmed by the user (i.e., the patient).
Product code
QFG Alternate Controller Enabled Insulin Infusion Pump
Reason for recall
The Czech language user guide contained multiple translation errors. The most significant error was that it incorrectly instructs users to verify that the infusion set is connected to the body, when it should instead direct users to confirm that the infusion set is not connected to the body. Following this instruction could result in unintended insulin delivery, potentially leading to a hypoglycemic event.
FDA root cause
Process change control
Action
On January 30, 2026, Tandem Diabetes Care issued a Urgent Medical Device Recall Notice to affected consignees via E-Mail. Tandem ask consignees to take the following actions: 1. Discard your existing User Guide. 2. Refer to the corrected User Guide version 7.8.1 which is available online at www.tandemdiabetes.com/cs-cz/support/resources/documents for accurate instructions on using your t:slim X2 Insulin Pump. 3. Physical copies of the corrected User Guide are being produced to replace the incorrect versions. If you would like a physical copy of the corrected User Guide, you may contact A. Import s customer service line to arrange for a replacement. 4.As requested above, please complete the online form acknowledging receipt of this notice. 5. Should you experience any device-related serious incidents, please report them to your distributor, a local contact point, or the State Institute for Drug Control.
Quantity in commerce
1,380 units
Distribution
International distribution in the countries of Czech Republic, Slovakia.
Product codes and lots
Version 7.8.1/ UDI: (01)008500066132625

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1636-2026
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1636-2026Class IIOngoingVoluntary: Firm initiated